Skip to main content

eChalk Talk: How to Ensure Pharmaceutical Product Success through Excipient QbD Efforts

Thank you

This live web event has ended. Thank you for attending.

Contributors

  • Kathryn Hewlett, Ph.D.

    Kathryn (Katie) Hewlett, PhD, is an Application Development & Innovation Scientist focused on pharmaceutical applications for IFF where she is responsible for educating and enabling customers on the performance enhancing benefits of performance excipients. In 2016, Katie transitioned to AD&I from R&D, where she was responsible for advancing modified-release drug delivery platforms, including application testing and development of technical data packages for multiple new product launches. Her areas of expertise include direct compression processes, modified release and Quality by Design. Katie has a BS in Materials Science and Engineering with a French minor from Stanford University. She earned her Ph.D. in Materials Science and Engineering from Northwestern University in 2011.

  • Mohammad Qadir, Ph.D.

    Mohammad Qadir holds a degree in Pharmacy, a Master’s in Pharmaceutical Analysis and a PhD in Drug Delivery and Formulation Design.

    Mohammad Qadir has over 12 years of experience in the pharmaceutical industry and academia, particularly in formulation design and delivery of various dosage forms with enhanced knowledge and expertise in controlled, sustained, delayed and pulsatile delivery. He mostly worked in R&D and possess extensive experience in drug product and combined device development from proof of concept to clinical trials. He previously worked with multinational companies within the UK and abroad. Mohammad has published and presented in multiple conferences across the globe.

October 27, 2021
Wed 11:15 AM EDT

Duration 0H 30M

This live web event has ended.

Event Support
1.703.243.2800